- Home
- GMGI vs TCRX Comparison
GMGI vs TCRX Comparison
Compare GMGI & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMGI
- TCRX
- Stock Information
- Founded
- GMGI 2008
- TCRX 2018
- Country
- GMGI United States
- TCRX United States
- Employees
- GMGI N/A
- TCRX N/A
- Industry
- GMGI Computer Software: Prepackaged Software
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- GMGI Technology
- TCRX Health Care
- Exchange
- GMGI Nasdaq
- TCRX Nasdaq
- Market Cap
- GMGI 145.9M
- TCRX 140.7M
- IPO Year
- GMGI N/A
- TCRX 2021
- Fundamental
- Price
- GMGI $0.98
- TCRX $1.23
- Analyst Decision
- GMGI Strong Buy
- TCRX Strong Buy
- Analyst Count
- GMGI 1
- TCRX 6
- Target Price
- GMGI $4.00
- TCRX $8.80
- AVG Volume (30 Days)
- GMGI 208.3K
- TCRX 939.4K
- Earning Date
- GMGI 10-30-2025
- TCRX 11-07-2025
- Dividend Yield
- GMGI N/A
- TCRX N/A
- EPS Growth
- GMGI N/A
- TCRX N/A
- EPS
- GMGI N/A
- TCRX N/A
- Revenue
- GMGI $179,142,103.00
- TCRX $6,961,000.00
- Revenue This Year
- GMGI $25.28
- TCRX $255.18
- Revenue Next Year
- GMGI $14.90
- TCRX N/A
- P/E Ratio
- GMGI N/A
- TCRX N/A
- Revenue Growth
- GMGI 37.24
- TCRX N/A
- 52 Week Low
- GMGI $0.87
- TCRX $1.02
- 52 Week High
- GMGI $3.00
- TCRX $5.92
- Technical
- Relative Strength Index (RSI)
- GMGI 45.75
- TCRX 32.85
- Support Level
- GMGI $0.87
- TCRX $1.02
- Resistance Level
- GMGI $1.03
- TCRX $1.17
- Average True Range (ATR)
- GMGI 0.07
- TCRX 0.16
- MACD
- GMGI 0.00
- TCRX -0.10
- Stochastic Oscillator
- GMGI 36.91
- TCRX 15.61
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.